{"id":"https://openalex.org/W4361239751","doi":"https://doi.org/10.1158/0008-5472.22398327","title":"Supplementary Methods, Figure Legend from In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors","display_name":"Supplementary Methods, Figure Legend from In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361239751","doi":"https://doi.org/10.1158/0008-5472.22398327"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22398327","doi":"https://doi.org/10.1158/0008-5472.22398327","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22398327","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legend_from_i_In_Vivo_i_MAPK_Reporting_Reveals_the_Heterogeneity_in_Tumoral_Selection_of_Resistance_to_RAF_Inhibitors/22398327/1/files/39844044.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legend_from_i_In_Vivo_i_MAPK_Reporting_Reveals_the_Heterogeneity_in_Tumoral_Selection_of_Resistance_to_RAF_Inhibitors/22398327/1/files/39844044.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033787308","display_name":"Kevin J. Basile","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin J. Basile","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029464243","display_name":"Ethan V. Abel","orcid":"https://orcid.org/0000-0003-2922-617X","observed_orcids":["https://orcid.org/0000-0003-2922-617X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ethan V. Abel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088302670","display_name":"Neda Dadpey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neda Dadpey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050694888","display_name":"Edward J. Hartsough","orcid":"https://orcid.org/0000-0002-5109-3978","observed_orcids":["https://orcid.org/0000-0002-5109-3978"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward J. Hartsough","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062228025","display_name":"Paolo M. Fortina","orcid":"https://orcid.org/0000-0002-5898-2081","observed_orcids":["https://orcid.org/0000-0002-5898-2081"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paolo Fortina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062746446","display_name":"Andrew E. Aplin","orcid":"https://orcid.org/0000-0002-2734-3244","observed_orcids":["https://orcid.org/0000-0002-2734-3244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Aplin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/raf-inhibitors","display_name":"RAF inhibitors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9229999780654907},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8759999871253967},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.8880000114440918},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.5561710000038147},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5080149173736572},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.46208545565605164},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37898463010787964},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36708080768585205},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3347221612930298},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.28726089000701904},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.19012829661369324},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.10406908392906189},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.06874862313270569}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22398327","doi":"https://doi.org/10.1158/0008-5472.22398327","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22398327","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legend_from_i_In_Vivo_i_MAPK_Reporting_Reveals_the_Heterogeneity_in_Tumoral_Selection_of_Resistance_to_RAF_Inhibitors/22398327/1/files/39844044.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22398327.v1","doi":"https://doi.org/10.1158/0008-5472.22398327.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22398327.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22398327","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legend_from_i_In_Vivo_i_MAPK_Reporting_Reveals_the_Heterogeneity_in_Tumoral_Selection_of_Resistance_to_RAF_Inhibitors/22398327","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22398327","doi":"https://doi.org/10.1158/0008-5472.22398327","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22398327","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_Figure_Legend_from_i_In_Vivo_i_MAPK_Reporting_Reveals_the_Heterogeneity_in_Tumoral_Selection_of_Resistance_to_RAF_Inhibitors/22398327/1/files/39844044.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.504800021648407,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361239751.pdf","grobid_xml":"https://content.openalex.org/works/W4361239751.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2011261819","https://openalex.org/W4361239872","https://openalex.org/W2062258918","https://openalex.org/W2038394683","https://openalex.org/W4248004733","https://openalex.org/W7220675282","https://openalex.org/W7097889279","https://openalex.org/W2954039126","https://openalex.org/W4361234424","https://openalex.org/W2293149121"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-31T00:00:00"}